Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "JC polyomavirus-infected cell" refers to any cell that has been infected by the human JC polyomavirus (JCPyV). JCPyV is a non-enveloped DNA virus that infects human cells—predominantly oligodendrocytes and astrocytes in the central nervous system—and can cause progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals[1][3]. The virus attaches via sialylated glycan motifs (e.g., lactoseries tetrasaccharide c, LSTc) and certain cell-surface receptors (e.g., serotonin receptor 5-HT2A) for entry, but infected cells themselves are not molecular targets; rather, they are the consequence of viral infection[1][3]. The phrase does not denote a defined and targetable molecule, receptor, enzyme, or transporter. There is a fundamental issue with this entry: it represents a disease state of a cell and not a molecular drug target. All structured fields are null except for "aliases" and "description," which clarify the usage and meaning of the term[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JC polyomavirus-infected cell.